Robert A Lookstein, MD MHCDL, FSIR FAHA, is Professor of Radiology and Surgery in the Division of Vascular and Interventional Radiology at Icahn School of Medicine at Mount Sinai (ISMMS). After attending medical school at the State University of NY (SUNY) Health Science Center at Brooklyn in 1995, he completed his radiology residency and fellowship in Vascular and Interventional Radiology at ISMMS in New York. He subsequently joined the division of Vascular and Interventional Radiology as Faculty in 2002.
Dr. Lookstein currently lectures around the world on various subjects in the field of Vascular and Interventional Radiology including peripheral arterial imaging and intervention, endovascular interventions, aortic stent-grafts, and deep vein thrombosis. He is recognized as an innovator in the field of peripheral vascular disease and noninvasive vascular imaging. His clinical practice is focused on the diagnosis and treatment of peripheral vascular disease.
Dr Lookstein currently serves as Vice Chairman in The Department of Radiology overseeing all Interventional Services for The Mount Sinai Health System. He is a Member of the Steering Committee of the American Heart Association's Council on Peripheral Arterial Disease. Dr. Lookstein serves as the Chair of the Society of Interventional Radiology (SIR) service line for peripheral arterial disease.
Dr. Lookstein is currently involved in numerous research studies related to peripheral vascular disease including the VENITE VICI venous stent trial, the RANGER study evaluating drug coated balloons in the femoral artery, the PRESERVE registry evaluating the safety and efficacy of Inferior Vena Cava filters, as well as the NHLBI funded BEST-CLI evaluating the role of endovascular revascularization for critical limb ischemia.
Dr. Lookstein has authored hundreds of scientific abstracts and manuscripts related to cardiovascular imaging and intervention and has served as Assistant Editor for the American Journal of Roentgenology.
He is a regular faculty member of numerous national and international meetings including The International Society of Endovascular Therapy, Advanced Interventional Management, The Society of Interventional Radiology Annual Scientific Meeting, The Radiologic Society of North America, and The American Heart Association, VIVA, and Transcatheter Cardiovascular Therapeutics. He is the Course Program Director of several national education courses including Lower Extremity Arterial RevascularizatioN (LEARN), TransRadial EndovAscular Therapy (TREAT).
Dr. Lookstein is the Clinical Director and Chief of the Division of Interventional Radiology. He serves on numerous committees within the Mount Sinai Health System related to patient safety and quality, novel procedure oversight, cardiovascular disease intervention value analysis, and performance improvement.
Atherosclerosis, Cardiovascular, Computed Tomography, Magnetic Resonance Imaging
MD, S.U.N.Y., Downstate Medical Center
Internship, Surgery (General)
Mount Sinai Hospital
Mount Sinai Hospital
Fellowship, Interventional Radiology
Mount Sinai Hospital
New York Magazine Top Doctors: Vascular Interventional Radiology
Castle Connelly Top Doctors - Vascular Interventional Radiology
New York Super Doctors - Radiology
Harold A Mitty Distinguished Educator Award in Interventional Radiology
Mount Sinai School of Medicine
Teacher of the Year
Radiology Residency Mount Sinai Medical Center Department of Radiology
Mount Sinai School of Medicine
Outstanding Faculty Award
Society of Interventional Radiology Annual Meeting
Inaugural Society of Interventional Radiology Leadership Academy
Fellow of the Society of Interventional Radiology (FSIR)
Fellow of the American Heart Association (FAHA)
Cohen E, Weinreb DB, Siegelbaum RH, Honig S, Marin M, Weintraub JL, Lookstein RA. Time-resolved MR angiography for the classification of endoleaks after endovascular aneurysm repair. J Magn Reson Imaging 2008 Feb 28; 27(3): 500-503.
Baril DT, Silverberg D, Ellozy SH, Carroccio A, Jacobs TS, Sachdev U, Teodorescu VJ, Lookstein RA, Marin ML. Endovascular stent-graft repair of failed endovascular abdominal aortic aneurysm repair. Ann Vasc Surg 2008 Jan; 22(1): 30-36.
Chang CY, Singal AK, Ganeshan SV, Schiano TD, Lookstein R, Emre S. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl 2007; 13(11): 1532-1537.
Talenfeld AD, Schwope RB, Alper HJ, Cohen E, Lookstein RA. MDCT angiography of the renal arteries in patients with atherosclerotic renal artery stenosis: implications for renal artery stenting with distal protection. AJR Am J Roentgenol 2007 Jun; 188(6): 1652-1658.
Shah AD, Bajakian DR, Olin JW, Lookstein RA. Power-pulse spray thrombectomy for treatment of paget-schroetter syndrome. AJR Am J Roentgenol 2007 May; 188(5): 1215-1217.
Baril DT, Lookstein RA, Jacobs TS, Won J, Marin ML. Durability of renal artery stents in patients with transrenal abdominal aortic endografts. J Vasc Surg 2007 May; 45(5): 915-921.
Schwope R, Alper H, Talenfeld A, Cohen E, Lookstein RA. MR Angiography for Patient Surveillance After Endovascular Repair of Abdominal Aortic Aneurysms. AJR Am J Roentgenol 2007; 188(4): W334-W340.
Sachdev U, Baril DT, Ellozy SH, Lookstein RA, Silverberg D, Jacobs TS, Carroccio A, Teodorescu VJ, Marin ML. Management of aneurysms involving branches of the celiac and superior mesenteric arteries: A comparison of surgical and endovascular therapy. J Vasc Surg 2006 Oct; 44(4): 718-724.
Silverberg D, Baril DT, Ellozy SH, Carroccio A, Greyrose SE, Lookstein RA, Marin ML. An 8-year experience with type II endoleaks: Natural history suggests selective intervention is a safe approach. J Vasc Surg 2006 Sep; 44(3): 453-459.
Axelrod DJ, Lookstein RA, Guller J, Nowakowski FS, Ellozy S, Carroccio A, Teodorescu V, Marin ML, Mitty HA. Inferior Mesenteric Artery Embolization before Endovascular Aneurysm Repair: Technique and Initial Results. J Vasc Interv Radiol 2004 Nov; 15(11): 1263-1267.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Lookstein during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.